Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Just Published! A New Book that Promises Inspiration to Transform Lives with Love and Kindness: Kennedy's Inspiring Story
Today 9:06 EST
From
Palmetto Publishing
Via
GlobeNewswire
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Today 9:05 EST
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Lincoln Tech to Expand Presence in Texas with New Rowlett Campus
Today 9:04 EST
From
Lincoln Tech
Via
GlobeNewswire
Tickers
LINC
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Today 9:01 EST
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Changes in Nokia Corporation's own shares
Today 9:00 EST
From
Nokia Oyj
Via
GlobeNewswire
Trump Media Reports Third Quarter 2025 Results
Today 9:00 EST
From
Trump Media & Technology Group
Via
GlobeNewswire
Tickers
DJT
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
Today 9:00 EST
From
Coherus Oncology, Inc.
Via
GlobeNewswire
Tickers
CHRS
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
Today 9:00 EST
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Tickers
ELTX
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Today 9:00 EST
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
NextNRG Reports Preliminary October 2025 Revenue Growth of 196% Year-Over-Year
Today 9:00 EST
From
NextNRG, Inc.
Via
GlobeNewswire
Tickers
NXXT
RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
Today 9:00 EST
From
Zhejiang Apollo Sports Technology Co., Ltd.
Via
GlobeNewswire
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025
Today 9:00 EST
From
Tizona Therapeutics Inc
Via
GlobeNewswire
ETC’s Commercial/Industrial Unit Awarded Contracts Totaling $9.1 Million
Today 9:00 EST
From
Environmental Tectonics Corporation
Via
GlobeNewswire
Tickers
ETCC
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Today 9:00 EST
From
T-knife Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
Today 9:00 EST
From
MiNK Therapeutics
Via
GlobeNewswire
Tickers
INKT
Fullmark Energy Announces Completion of Redwood Projects Portfolio with Commercial Operations of 65MW San Jacinto Energy Storage Project
Today 9:00 EST
From
Fullmark Energy
Via
GlobeNewswire
Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
Today 9:00 EST
From
Wearable Devices Ltd.
Via
GlobeNewswire
Tickers
WLDS
WLDSW
Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
Today 9:00 EST
From
Legrand North & Central America
Via
GlobeNewswire
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
Today 9:00 EST
From
BioAge Labs, Inc.
Via
GlobeNewswire
Tickers
BIOA
CTS Corporation Declares a Dividend and Share Repurchase Program
Today 9:00 EST
From
CTS Corporation
Via
GlobeNewswire
Tickers
CTS
Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
Today 9:00 EST
From
Flare Therapeutics Inc.
Via
GlobeNewswire
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
Today 9:00 EST
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
Tickers
NTHI
EQ Appoints Nicholas Nichols as Executive Vice President of Mutual Funds
Today 9:00 EST
From
EQ
Via
GlobeNewswire
Creative Realities Closes Acquisition of Cineplex Digital Media
Today 9:00 EST
From
Creative Realities
Via
GlobeNewswire
Tickers
CREX
TSX:CGX
H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
Today 9:00 EST
From
H/Advisors Abernathy
Via
GlobeNewswire
American Battery Technology Company Announces First Quarter Fiscal 2026 Financial Results
Today 8:53 EST
From
American Battery Technology Company
Via
GlobeNewswire
Tickers
ABAT
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
Today 8:45 EST
From
Neurogastrx
Via
GlobeNewswire
Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue
Today 8:42 EST
From
Ipsen Pharma
Via
GlobeNewswire
Bosuer Electrifies EICMA 2025 with Strategic Debut of Its High-Performance Off-Road Matrix
Today 8:30 EST
From
Zhejiang Bosuer Motion Apparatus Co., Ltd.
Via
GlobeNewswire
Navitas Announces Private Placement of Common Stock for Proceeds of $100 Million
Today 8:30 EST
From
Navitas Semiconductor Corporation
Via
GlobeNewswire
Tickers
NVTS
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.